AF
Apexium Financial Portfolio holdings
AUM
$1.88B
1-Year Return
13.34%
This Quarter Return
+10.18%
1 Year Return
+13.34%
3 Year Return
+66.17%
5 Year Return
+102.04%
10 Year Return
–
AUM
$1.88B
AUM Growth
+$208M
(+12%)
Cap. Flow
+$54.7M
Cap. Flow
% of AUM
2.9%
Top 10 Holdings %
Top 10 Hldgs %
61.81%
Holding
288
New
10
Increased
131
Reduced
104
Closed
10
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
$16.2M |
| 2 |
iShares US Tech Independence Focused ETF
IETC
|
$4.81M |
| 3 |
Vanguard Total Bond Market
BND
|
$4.56M |
| 4 |
Strategic Trust Running Oak Efficient Growth ETF
RUNN
|
$4.42M |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
$4.34M |
Top Sells
| 1 |
WisdomTree Floating Rate Treasury Fund
USFR
|
$2.79M |
| 2 |
JPMorgan Chase
JPM
|
$2.6M |
| 3 |
iShares Expanded Tech Sector ETF
IGM
|
$2.58M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
$1.81M |
| 5 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
$1.18M |
Sector Composition
| 1 | Technology | 6.6% |
| 2 | Communication Services | 2.22% |
| 3 | Financials | 2.14% |
| 4 | Consumer Discretionary | 0.85% |
| 5 | Healthcare | 0.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Main Street Capital
MAIN
$5.96B
| $321K | 0.02% |
5,435
| – | – |
|
227
Novartis
NVS
$249B
| $316K | 0.02% |
2,613
+469
| +22% | +$56.8K |
|
228
Vanguard FTSE Europe ETF
VGK
$26.7B
| $314K | 0.02% |
4,052
+11
| +0.3% | +$853 |
|
229
Zscaler
ZS
$41.8B
| $314K | 0.02% |
+1,000
| New | +$314K |
|
230
Hologic
HOLX
$14.8B
| $313K | 0.02% |
4,798
+75
| +2% | +$4.89K |
|
231
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$41.9B
| $310K | 0.02% |
3,381
+445
| +15% | +$40.8K |
|
232
Pfizer
PFE
$140B
| $295K | 0.02% |
12,158
-2,445
| -17% | -$59.3K |
|
233
Linde
LIN
$222B
| $288K | 0.02% |
613
+91
| +17% | +$42.7K |
|
234
SPDR S&P MidCap 400 ETF Trust
MDY
$23.9B
| $281K | 0.01% |
496
| – | – |
|
235
Intuitive Surgical
ISRG
$163B
| $274K | 0.01% |
504
+32
| +7% | +$17.4K |
|
236
iShares Russell Mid-Cap ETF
IWR
$44.5B
| $270K | 0.01% |
2,937
+7
| +0.2% | +$644 |
|
237
Aflac
AFL
$58.1B
| $269K | 0.01% |
2,552
-551
| -18% | -$58.1K |
|
238
Fidelity MSCI Real Estate Index ETF
FREL
$1.05B
| $264K | 0.01% |
9,757
-137
| -1% | -$3.71K |
|
239
TSMC
TSM
$1.22T
| $263K | 0.01% |
+1,161
| New | +$263K |
|
240
Union Pacific
UNP
$132B
| $261K | 0.01% |
1,135
+18
| +2% | +$4.14K |
|
241
Lowe's Companies
LOW
$148B
| $260K | 0.01% |
1,170
-6
| -0.5% | -$1.33K |
|
242
Truist Financial
TFC
$60.7B
| $259K | 0.01% |
6,018
+587
| +11% | +$25.2K |
|
243
Blue Owl Capital
OBDC
$7.34B
| $252K | 0.01% |
17,581
+81
| +0.5% | +$1.16K |
|
244
Invesco Pharmaceuticals ETF
PJP
$264M
| $251K | 0.01% |
3,146
| – | – |
|
245
iShares Core MSCI Europe ETF
IEUR
$6.82B
| $251K | 0.01% |
3,794
-2,367
| -38% | -$157K |
|
246
Northrop Grumman
NOC
$83B
| $250K | 0.01% |
501
-83
| -14% | -$41.5K |
|
247
iShares MSCI Emerging Markets ETF
EEM
$19B
| $248K | 0.01% |
+5,138
| New | +$248K |
|
248
Colgate-Palmolive
CL
$67.6B
| $245K | 0.01% |
2,696
-250
| -8% | -$22.7K |
|
249
TriMas Corp
TRS
$1.6B
| $243K | 0.01% |
+8,500
| New | +$243K |
|
250
RenaissanceRe
RNR
$11.5B
| $243K | 0.01% |
1,000
| – | – |
|